n-Lorem is focused on creating individual treatments for patients in the United States with nano-rare diseases caused by genetic mutations that affect approximately 1-30 patients in the world. Diseases or conditions with broader patent populations are likely more suitable for treatment by other non-profit or for-profit entities, which we encourage you to explore with your physician.